UHN Inpatient Hepatitis C & B Screening

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,920

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Hepatitis CHepatitis B
Interventions
OTHER

Quality Improvement

Rapid Point-of-Care testing will provide participants with a HCV antibody and RNA result within 2 hours. If the participant is HCV RNA+, they will receive an inpatient consultation from a liver specialist prior to discharge. We hypothesize that this model will minimize losses in the continuum-of-care and improve linkages to care.

Trial Locations (2)

M5G 2C4

RECRUITING

Toronto General Hospital, Toronto

M5T 2S8

RECRUITING

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

Jordan Feld

OTHER